John J. Nicols serves as President, Chief Executive Officer, Director of Codexis, Inc. Mr. Nicols brings to our board of directors his knowledge of Codexis as its President and Chief Executive Officer and his extensive prior management experience in the chemicals industry. Prior to that time, Mr. Nicols served in various capacities at Albemarle Corporation, a public company focused on the development, manufacture and marketing of highly engineered specialty chemicals, since he joined that company in 1990. Mr. Nicols most recently served as its Senior Vice President, Strategic Development and Catalysts, from March 2012 to June 2012. Mr. Nicols previously served as its Vice President, Catalysts from January 2007 to February 2012, its Vice President, Fine Chemistry from June 2002 to December 2006, its Division Vice President, Global Flame Retardants business from February 1999 through June 2002 and its Asia Pacific Business Director for the Bromine Chemicals business, based in Tokyo, Japan, from 1995 to 1998. Prior to his time with Albemarle Corporation, Mr. Nicols worked for three years in manufacturing and research and development for Hercules, Inc. Mr. Nicols has served on the board of directors of California Life Sciences Association (formerly BayBio), a non-profit organization, since January 2014. In addition, Mr. Nicols has served on the board of directors of Solve ME/CFS Initiative, a non-profit organization, since January 2015, and currently serves as chairperson and on the executive and nominating committees of that organization. Mr. Nicols received a B.S. in Chemical Engineering from the Polytechnic Institute of New York University and an M.B.A. from the Sloan School of Management at the Massachusetts Institute of Technology.
What is John J. Nicols' net worth?
The estimated net worth of John J. Nicols is at least $2.08 million as of April 18th, 2023. Mr. Nicols owns 783,965 shares of Codexis stock worth more than $2,077,507 as of April 25th. This net worth estimate does not reflect any other investments that Mr. Nicols may own. Learn More about John J. Nicols' net worth.
How do I contact John J. Nicols?
Has John J. Nicols been buying or selling shares of Codexis?
John J. Nicols has not been actively trading shares of Codexis within the last three months. Most recently, John J. Nicols sold 35,714 shares of the business's stock in a transaction on Tuesday, April 18th. The shares were sold at an average price of $4.14, for a transaction totalling $147,855.96. Following the completion of the sale, the director now directly owns 783,965 shares of the company's stock, valued at $3,245,615.10. Learn More on John J. Nicols' trading history.
Who are Codexis' active insiders?
Are insiders buying or selling shares of Codexis?
In the last year, Codexis insiders bought shares 3 times. They purchased a total of 32,484 shares worth more than $55,402.80. In the last year, insiders at the biotechnology company sold shares 1 times. They sold a total of 20,000 shares worth more than $42,200.00. The most recent insider tranaction occured on November, 15th when Director Byron L Dorgan sold 20,000 shares worth more than $42,200.00. Insiders at Codexis own 6.3% of the company.
Learn More about insider trades at Codexis. Information on this page was last updated on 11/15/2023.
